Apogee Therapeutics (APGE) Stock: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$135.07
-0.01 (-0.01%)
▼
5d:
+0.09%
30d:
+0.66%
90d:
+60.43%
HOLD
MODERATE Confidence
Analysis Updated: Sep 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APGE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APGE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $135.07, which is considered fair based on recent price action.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is currently testing key support at $134.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
54/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Protect Your Profits
APGE is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- NEUTRAL: Near Wall St target ($134.85)
- NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation
Support & Resistance Levels
Support Level
$134.68
Resistance Level
$135.09
Current Trend
Strong Uptrend
Technical data as of
Sep 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.81
Wall Street Target
$134.85
(-0.2%)
Share & Embed Analysis
Last updated: October 22, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 72 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 70 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 71 BUY |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 76 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$283 | 51 HOLD |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
